Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non-small cell lung cancer: A network meta-analysis

The present network meta-analysis aimed to compare the effectiveness and adverse effects of gefitinib, erlotinib and icotinib in the treatment of patients with non-small cell lung cancer (NSCLC). Two reviewers searched the Cochrane, PubMed, Embase, ScienceDirect, China National Knowledge Infrastruct...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuanyuan, Zhang, Yu, Feng, Gangling, Niu, Qiang, Xu, Shangzhi, Yan, Yizhong, Li, Shugang, Jing, Mingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658684/
https://www.ncbi.nlm.nih.gov/pubmed/29104622
http://dx.doi.org/10.3892/etm.2017.5094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658684/
https://www.ncbi.nlm.nih.gov/pubmed/29104622
http://dx.doi.org/10.3892/etm.2017.5094

Ejemplares similares